China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds ...

China's biotechnology sector is experiencing notable growth, with the ChinaAMC Hang Seng Biotech ETF, tracking the Hang Seng ...

Recent federal actions could derail decades of progress. Meanwhile China has prioritized investment in biotech.

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

Biotech stock Zai Lab slipped as investors digested ... It serves patients in China, the U.S. and Europe. The China-based company has expanded its presence and now has three offices in the U.S ...

Overall, this saw China-based biotech firms increase their market ... However, if the Chinese biotech sector is going to continue its growth trajectory, certain other aspects beyond investment ...

There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising ...

"China's biotechnology sector thrives on a dual engine ... "China's biopharmaceutical market is rapidly evolving, with significant growth and a strong focus on innovation." ...

The "China Biotechnology Directory 2025" has been added to ResearchAndMarkets.com's offering. The Chinese biotechnology industry has increased with high annual average growth rates over the last ...